Metraipolis › archive › dc_9df44d4085d3

Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review — Europe PMC PMID:40951222

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40951222
DOI
10.7759/cureus.90021
License (as archived)
solo-consultazione
Archived
2026-11-10T16:19:24.024Z
SHA-256 of the archived text
97b3cdb2ee44945308997d27622d5b9b3e26eb78700255c4b7944fc9dab98bfa
Stable URL of this page
https://metraipolis.com/documento/dc_9df44d4085d3

How to cite

Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review — Europe PMC PMID:40951222 — Europe PMC (en), https://europepmc.org/article/MED/40951222 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9df44d4085d3 (Metraipolis archive dc_9df44d4085d3, sha256 97b3cdb2ee44945308997d27622d5b9b3e26eb78700255c4b7944fc9dab98bfa)
BibTeX
@misc{dc9df44d4085d3,
  title = {Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review — Europe PMC PMID:40951222},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40951222},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9df44d4085d3; sha256 97b3cdb2ee44945308997d27622d5b9b3e26eb78700255c4b7944fc9dab98bfa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40951222. Agents can read the archived copy with the MCP tool read_document.